Patricia Guerrero

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Journal: BJU international

Published: March 03, 2026

Toxicity Profile of New Therapies in Metastatic Urothelial Carcinoma and Its Impact on Treatment Selection.

Toxicity Profile of New Therapies in Metastatic Urothelial Carcinoma and Its Impact on Treatment Selection.

Journal: Cancers

Published: September 15, 2025

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Journal: The oncologist

Published: April 15, 2024

Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent.

Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent.

Journal: Cancer immunology, immunotherapy : CII

Published: March 24, 2024

Adoptive T cell therapy for solid tumors: current landscape and future challenges.

Adoptive T cell therapy for solid tumors: current landscape and future challenges.

Journal: Frontiers in immunology

Published: December 08, 2023

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature.

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature.

Journal: Cancers

Published: September 25, 2023

Current Landscape of Immunotherapy for Advanced Sarcoma.

Current Landscape of Immunotherapy for Advanced Sarcoma.

Journal: Cancers

Published: March 18, 2023

Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.

Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.

Journal: International journal of molecular sciences

Published: October 06, 2022

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.

Journal: International journal of molecular sciences

Published: September 28, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026